Condensed Consolidated Statements of Cash Flow (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities
Net income / (loss)	$ 8,264	$ (854,102)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	15,075	15,328
Deferred income taxes	(1,948)	(5,138)
Unrealized foreign exchange gains	(77,591)	118,366
Stock options fair value expense	1,919	1,998
Equity loss in affiliates	0	7,946
Gain on fair value remeasurement of previously held equity interest	0	(6,397)
Impairment charge	0	674,515
Impairments related to assets held for sale	0	7,355
Other non cash items	849	6,170
Changes in operating assets and liabilities:
Accounts receivable	211,483	246,153
Inventories	(33,969)	(9,183)
Prepayments and other current assets	(42,447)	(7,701)
Trade accounts payable	(78,804)	(42,518)
Other accrued liabilities and payables (including taxes)	(71,829)	(106,396)
Net cash provided by / (used in) operating activities	(68,998)	46,396
Cash flows from investing activities
Purchase of fixed assets	(8,017)	(5,422)
Proceeds from the disposal of fixed assets	381	0
Purchase of intangibles	0	(693)
Purchase of trademarks	0	(17,473)
Acquisitions of subsidiaries, net of cash acquired	0	(24,125)
Net cash used in investing activities	(7,636)	(47,713)
Cash flows from financing activities
Borrowings on bank loans and overdraft facility	78,177	36,027
Payment of bank loans, overdraft facility and other borrowings	(45,439)	(37,892)
Issuance of Debt Security, net of debt issuance cost of $838	69,162	0
Repayment of Convertible Senior Notes	(50,392)	0
Issuance of shares in private placement	29,885	0
Decrease in short term capital leases payable	(252)	(34)
Proceeds from options exercised	0	72
Net cash provided by / (used in) financing activities	81,141	(1,827)
Currency effect on brought forward cash balances	3,796	(7,781)
Net increase / (decrease) in cash	8,303	(10,925)
Cash and cash equivalents at beginning of period	94,410	122,116
Cash and cash equivalents at end of period	102,713	111,191
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries	$ 0	$ 23,175